Drug Discovery Outsourcing Market 2024-2028

Report
166 Pages
March 2024
Region: Global
TechNavio
ID: 5415956

The drug discovery outsourcing market is forecasted to grow by USD 1.79 bn during 2023-2028, accelerating at a CAGR of 7.44% during the forecast period. The report on the drug discovery outsourcing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by robust demand for biosimilars, prioritization of core competencies, and an increased number of FDA-approved manufacturing facilities in developing nations.

The drug discovery outsourcing market is segmented as below:

By Product

Small-molecules
Biologics

By End-user

Big pharmaceutical companies
Small and medium-sized pharmaceutical companies
Generic pharmaceutical companies

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the technological advancements boosting drug discovery outsourcing as one of the prime reasons driving the drug discovery outsourcing market growth during the next few years. Also, increased demand for regenerative medicine and cost reduction and efficiency-boosting demand for drug discovery outsourcing will lead to sizable demand in the market.

The report on the drug discovery outsourcing market covers the following areas:

Drug discovery outsourcing market sizing
Drug discovery outsourcing market forecast
Drug discovery outsourcing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading drug discovery outsourcing market vendors that include Aragen Life Sciences Pvt. Ltd., Aurigene Discovery Technologies, Catalent Inc., Charles River Laboratories International Inc., Curia Global Inc., Domainex, Eurofins Scientific SE, Evotec SE, GenScript Biotech Corp., LABORATORY CORPORATION OF AMERICA HOLDINGS, Lonza Group Ltd., Lupin Ltd., Novotech Health Holdings, Oncodesign Services, PerkinElmer Inc, QIAGEN NV, Shanghai Medicilon Inc., Syngene International Ltd., Thermo Fisher Scientific Inc., and WuXi AppTec Co. Ltd. Also, the drug discovery outsourcing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global drug discovery outsourcing market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global drug discovery outsourcing market 2018 - 2022 ($ billion)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Small-molecules - Market size and forecast 2023-2028
Exhibit 34: Chart on Small-molecules - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Small-molecules - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Small-molecules - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Small-molecules - Year-over-year growth 2023-2028 (%)
6.4 Biologics - Market size and forecast 2023-2028
Exhibit 38: Chart on Biologics - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Biologics - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Biologics - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ billion)
Exhibit 43: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by End-user

7.1 Market segments
Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 46: Chart on Comparison by End-user
Exhibit 47: Data Table on Comparison by End-user
7.3 Big pharmaceutical companies - Market size and forecast 2023-2028
Exhibit 48: Chart on Big pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 49: Data Table on Big pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 50: Chart on Big pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Big pharmaceutical companies - Year-over-year growth 2023-2028 (%)
7.4 Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028
Exhibit 52: Chart on Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Small and medium-sized pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Small and medium-sized pharmaceutical companies - Year-over-year growth 2023-2028 (%)
7.5 Generic pharmaceutical companies - Market size and forecast 2023-2028
Exhibit 56: Chart on Generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Generic pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Generic pharmaceutical companies - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by End-user
Exhibit 60: Market opportunity by End-user ($ billion)
Exhibit 61: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Aragen Life Sciences Pvt. Ltd.
Exhibit 111: Aragen Life Sciences Pvt. Ltd. - Overview
Exhibit 112: Aragen Life Sciences Pvt. Ltd. - Product / Service
Exhibit 113: Aragen Life Sciences Pvt. Ltd. - Key offerings
12.4 Catalent Inc.
Exhibit 114: Catalent Inc. - Overview
Exhibit 115: Catalent Inc. - Business segments
Exhibit 116: Catalent Inc. - Key offerings
Exhibit 117: Catalent Inc. - Segment focus
12.5 Charles River Laboratories International Inc.
Exhibit 118: Charles River Laboratories International Inc. - Overview
Exhibit 119: Charles River Laboratories International Inc. - Business segments
Exhibit 120: Charles River Laboratories International Inc. - Key news
Exhibit 121: Charles River Laboratories International Inc. - Key offerings
Exhibit 122: Charles River Laboratories International Inc. - Segment focus
12.6 Curia Global Inc.
Exhibit 123: Curia Global Inc. - Overview
Exhibit 124: Curia Global Inc. - Product / Service
Exhibit 125: Curia Global Inc. - Key offerings
12.7 Domainex
Exhibit 126: Domainex - Overview
Exhibit 127: Domainex - Product / Service
Exhibit 128: Domainex - Key offerings
12.8 Eurofins Scientific SE
Exhibit 129: Eurofins Scientific SE - Overview
Exhibit 130: Eurofins Scientific SE - Business segments
Exhibit 131: Eurofins Scientific SE - Key news
Exhibit 132: Eurofins Scientific SE - Key offerings
Exhibit 133: Eurofins Scientific SE - Segment focus
12.9 Evotec SE
Exhibit 134: Evotec SE - Overview
Exhibit 135: Evotec SE - Business segments
Exhibit 136: Evotec SE - Key offerings
Exhibit 137: Evotec SE - Segment focus
12.10 GenScript Biotech Corp.
Exhibit 138: GenScript Biotech Corp. - Overview
Exhibit 139: GenScript Biotech Corp. - Business segments
Exhibit 140: GenScript Biotech Corp. - Key offerings
Exhibit 141: GenScript Biotech Corp. - Segment focus
12.11 LABORATORY CORPORATION OF AMERICA HOLDINGS
Exhibit 142: LABORATORY CORPORATION OF AMERICA HOLDINGS - Overview
Exhibit 143: LABORATORY CORPORATION OF AMERICA HOLDINGS - Business segments
Exhibit 144: LABORATORY CORPORATION OF AMERICA HOLDINGS - Key news
Exhibit 145: LABORATORY CORPORATION OF AMERICA HOLDINGS - Key offerings
Exhibit 146: LABORATORY CORPORATION OF AMERICA HOLDINGS - Segment focus
12.12 Lonza Group Ltd.
Exhibit 147: Lonza Group Ltd. - Overview
Exhibit 148: Lonza Group Ltd. - Business segments
Exhibit 149: Lonza Group Ltd. - Key news
Exhibit 150: Lonza Group Ltd. - Key offerings
Exhibit 151: Lonza Group Ltd. - Segment focus
12.13 Lupin Ltd.
Exhibit 152: Lupin Ltd. - Overview
Exhibit 153: Lupin Ltd. - Product / Service
Exhibit 154: Lupin Ltd. - Key news
Exhibit 155: Lupin Ltd. - Key offerings
12.14 Oncodesign Services
Exhibit 156: Oncodesign Services - Overview
Exhibit 157: Oncodesign Services - Product / Service
Exhibit 158: Oncodesign Services - Key offerings
12.15 PerkinElmer Inc
Exhibit 159: PerkinElmer Inc - Overview
Exhibit 160: PerkinElmer Inc - Business segments
Exhibit 161: PerkinElmer Inc - Key news
Exhibit 162: PerkinElmer Inc - Key offerings
Exhibit 163: PerkinElmer Inc - Segment focus
12.16 QIAGEN NV
Exhibit 164: QIAGEN NV - Overview
Exhibit 165: QIAGEN NV - Product / Service
Exhibit 166: QIAGEN NV - Key offerings
12.17 Thermo Fisher Scientific Inc.
Exhibit 167: Thermo Fisher Scientific Inc. - Overview
Exhibit 168: Thermo Fisher Scientific Inc. - Business segments
Exhibit 169: Thermo Fisher Scientific Inc. - Key news
Exhibit 170: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 171: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 172: Inclusions checklist
Exhibit 173: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 174: Currency conversion rates for US$
13.4 Research methodology
Exhibit 175: Research methodology
Exhibit 176: Validation techniques employed for market sizing
Exhibit 177: Information sources
13.5 List of abbreviations
Exhibit 178: List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global drug discovery outsourcing market 2018 - 2022 ($ billion)
Exhibits 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
Exhibits 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Product - Market share 2023-2028 (%)
Exhibits 31: Data Table on Product - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on Small-molecules - Market size and forecast 2023-2028 ($ billion)
Exhibits 35: Data Table on Small-molecules - Market size and forecast 2023-2028 ($ billion)
Exhibits 36: Chart on Small-molecules - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Small-molecules - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Biologics - Market size and forecast 2023-2028 ($ billion)
Exhibits 39: Data Table on Biologics - Market size and forecast 2023-2028 ($ billion)
Exhibits 40: Chart on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by Product ($ billion)
Exhibits 43: Data Table on Market opportunity by Product ($ billion)
Exhibits 44: Chart on End-user - Market share 2023-2028 (%)
Exhibits 45: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 46: Chart on Comparison by End-user
Exhibits 47: Data Table on Comparison by End-user
Exhibits 48: Chart on Big pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibits 49: Data Table on Big pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibits 50: Chart on Big pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Big pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits 52: Chart on Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibits 53: Data Table on Small and medium-sized pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibits 54: Chart on Small and medium-sized pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Small and medium-sized pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits 56: Chart on Generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibits 57: Data Table on Generic pharmaceutical companies - Market size and forecast 2023-2028 ($ billion)
Exhibits 58: Chart on Generic pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits 59: Data Table on Generic pharmaceutical companies - Year-over-year growth 2023-2028 (%)
Exhibits 60: Market opportunity by End-user ($ billion)
Exhibits 61: Data Table on Market opportunity by End-user ($ billion)
Exhibits 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 65: Chart on Geographic comparison
Exhibits 66: Data Table on Geographic comparison
Exhibits 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 88: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 96: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 103: Market opportunity By Geographical Landscape ($ billion)
Exhibits 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 105: Impact of drivers and challenges in 2023 and 2028
Exhibits 106: Overview on Criticality of inputs and Factors of differentiation
Exhibits 107: Overview on factors of disruption
Exhibits 108: Impact of key risks on business
Exhibits 109: Vendors covered
Exhibits 110: Matrix on vendor position and classification
Exhibits 111: Aragen Life Sciences Pvt. Ltd. - Overview
Exhibits 112: Aragen Life Sciences Pvt. Ltd. - Product / Service
Exhibits 113: Aragen Life Sciences Pvt. Ltd. - Key offerings
Exhibits 114: Catalent Inc. - Overview
Exhibits 115: Catalent Inc. - Business segments
Exhibits 116: Catalent Inc. - Key offerings
Exhibits 117: Catalent Inc. - Segment focus
Exhibits 118: Charles River Laboratories International Inc. - Overview
Exhibits 119: Charles River Laboratories International Inc. - Business segments
Exhibits 120: Charles River Laboratories International Inc. - Key news
Exhibits 121: Charles River Laboratories International Inc. - Key offerings
Exhibits 122: Charles River Laboratories International Inc. - Segment focus
Exhibits 123: Curia Global Inc. - Overview
Exhibits 124: Curia Global Inc. - Product / Service
Exhibits 125: Curia Global Inc. - Key offerings
Exhibits 126: Domainex - Overview
Exhibits 127: Domainex - Product / Service
Exhibits 128: Domainex - Key offerings
Exhibits 129: Eurofins Scientific SE - Overview
Exhibits 130: Eurofins Scientific SE - Business segments
Exhibits 131: Eurofins Scientific SE - Key news
Exhibits 132: Eurofins Scientific SE - Key offerings
Exhibits 133: Eurofins Scientific SE - Segment focus
Exhibits 134: Evotec SE - Overview
Exhibits 135: Evotec SE - Business segments
Exhibits 136: Evotec SE - Key offerings
Exhibits 137: Evotec SE - Segment focus
Exhibits 138: GenScript Biotech Corp. - Overview
Exhibits 139: GenScript Biotech Corp. - Business segments
Exhibits 140: GenScript Biotech Corp. - Key offerings
Exhibits 141: GenScript Biotech Corp. - Segment focus
Exhibits 142: LABORATORY CORPORATION OF AMERICA HOLDINGS - Overview
Exhibits 143: LABORATORY CORPORATION OF AMERICA HOLDINGS - Business segments
Exhibits 144: LABORATORY CORPORATION OF AMERICA HOLDINGS - Key news
Exhibits 145: LABORATORY CORPORATION OF AMERICA HOLDINGS - Key offerings
Exhibits 146: LABORATORY CORPORATION OF AMERICA HOLDINGS - Segment focus
Exhibits 147: Lonza Group Ltd. - Overview
Exhibits 148: Lonza Group Ltd. - Business segments
Exhibits 149: Lonza Group Ltd. - Key news
Exhibits 150: Lonza Group Ltd. - Key offerings
Exhibits 151: Lonza Group Ltd. - Segment focus
Exhibits 152: Lupin Ltd. - Overview
Exhibits 153: Lupin Ltd. - Product / Service
Exhibits 154: Lupin Ltd. - Key news
Exhibits 155: Lupin Ltd. - Key offerings
Exhibits 156: Oncodesign Services - Overview
Exhibits 157: Oncodesign Services - Product / Service
Exhibits 158: Oncodesign Services - Key offerings
Exhibits 159: PerkinElmer Inc - Overview
Exhibits 160: PerkinElmer Inc - Business segments
Exhibits 161: PerkinElmer Inc - Key news
Exhibits 162: PerkinElmer Inc - Key offerings
Exhibits 163: PerkinElmer Inc - Segment focus
Exhibits 164: QIAGEN NV - Overview
Exhibits 165: QIAGEN NV - Product / Service
Exhibits 166: QIAGEN NV - Key offerings
Exhibits 167: Thermo Fisher Scientific Inc. - Overview
Exhibits 168: Thermo Fisher Scientific Inc. - Business segments
Exhibits 169: Thermo Fisher Scientific Inc. - Key news
Exhibits 170: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 171: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 172: Inclusions checklist
Exhibits 173: Exclusions checklist
Exhibits 174: Currency conversion rates for US$
Exhibits 175: Research methodology
Exhibits 176: Validation techniques employed for market sizing
Exhibits 177: Information sources
Exhibits 178: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global drug discovery outsourcing market: Aragen Life Sciences Pvt. Ltd., Aurigene Discovery Technologies, Catalent Inc., Charles River Laboratories International Inc., Curia Global Inc., Domainex, Eurofins Scientific SE, Evotec SE, GenScript Biotech Corp., LABORATORY CORPORATION OF AMERICA HOLDINGS, Lonza Group Ltd., Lupin Ltd., Novotech Health Holdings, Oncodesign Services, PerkinElmer Inc, QIAGEN NV, Shanghai Medicilon Inc., Syngene International Ltd., Thermo Fisher Scientific Inc., and WuXi AppTec Co. Ltd.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is technological advancements boosting drug discovery outsourcing."

According to the report, one of the major drivers for this market is the robust demand for biosimilars.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Aragen Life Sciences Pvt. Ltd.
Aurigene Discovery Technologies
Catalent Inc.
Charles River Laboratories International Inc.
Curia Global Inc.
Domainex
Eurofins Scientific SE
Evotec SE
GenScript Biotech Corp.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Lonza Group Ltd.
Lupin Ltd.
Novotech Health Holdings
Oncodesign Services
PerkinElmer Inc
QIAGEN NV
Shanghai Medicilon Inc.
Syngene International Ltd.
Thermo Fisher Scientific Inc.
WuXi AppTec Co. Ltd.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2400EUR$2,500USD£1,995GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3839EUR$4,000USD£3,193GBP

The drug discovery outsourcing market is segmented as below:

By Product

By End-user

By Geographical Landscape

The report on the drug discovery outsourcing market covers the following areas:

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Related Topics

Related Reports

Drug Discovery Informatics Market 2024-2028

Toxicology Testing Market 2024-2028

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Report 2024

Drug Discovery Services Global Market Report 2024

Drug Discovery Services - Global Strategic Business Report